Low-temperature oxidation of Fe(2)(S(2)C(n)H(2n)(CNMe)(6-x)(CO)x (n = 2, 3; x = 2, 3) affords a family of mixed carbonyl-isocyanides of the type [Fe(2)(S(2)C(n)H(2n)(CO)x(CNMe)(7-x)](2+). The degree of substitution is controlled by the RNC/Fe ratio, as well as the degree of initial substitution at iron, with tricarbonyl derivatives favoring more highly carbonylated products. The structures of the monocarbonyl derivatives [Fe(2)(S(2)C(n)H(2n))(mu-CO)(CNMe)(6)](PF(6))(2) (n = 2,3) established crystallographically and spectroscopically, are quite similar, with Fe---Fe distances of ca. 2.5 A, although the mu-CO is unsymmetrical in the propanedithiolate derivative. Isomeric forms of [Fe(2)(S(2)C(3)H(6))(CO)(CNMe)(6)](PF(6))(2) were characterized where the CO is bridging or terminal, the greatest structural difference being the 0.1 A elongation of the Fe---Fe distance when MeNC (vs CO) is bridging. In the dicarbonyl species, [Fe(2)(S(2)C(2)H(4))(mu-CO)(CO)(CNMe)(5)](PF(6))(2), the terminal CO ligand is situated at one of the basal sites, not trans to the Fe---Fe vector. Oxidation of Fe(2)(S(2)C(2)H(4))(CNMe)(3)(CO)(3) under 1 atm CO gives the deep pink tricarbonyl [Fe(2)(S(2)C(2)H(4))(CO)(3)(CNMe)(4)](PF(6))(2). DFT calculations show that a bridging CO or MeNC establishes a 3-center, 2-electron bond within the two Fe(II) centers, which would otherwise be nonbonding.
No takes yet. Share an insight, caveat, or question.
Boyke et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: